NOTE REGARDING FORWARD-LOOKING STATEMENTS
This prospectus includes forward-looking statements within the meaning of the federal securities laws that involve risks and uncertainties concerning our business, products and financial results. All statements other than statements of historical facts contained in this prospectus, including statements concerning possible or assumed future actions, business strategies, events or results of operations, and any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.
In some cases, you can identify forward-looking statements by terms such as "may," "should," "expect," "plan," "anticipate," "could," "intend," "target," "project," "contemplate," "believe," "estimate," "predict," "potential" or "continue" or the negative of these terms or other similar expressions. The forward-looking statements in this prospectus are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that the future results, levels of activity, performance or events and circumstances reflected in the forward-looking statements will be achieved or occur. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you should not rely on these forward-looking statements as predictions of future events. The events and circumstances reflected in our forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements. Some of the key factors that could cause actual results to differ from our expectations include, but are not limited to, the following:
•
the ability to maintain the listing of our common stock on the NYSE American;
•
our public securities' potential liquidity and trading;
•
our capital requirements and ability to raise financing in the future and continue as a going concern;
•
our success in retaining or recruiting, or changes required in, officers, key employees or directors;
•
factors relating to our business, operations and financial performance;
•
the initiation, cost, timing, progress and results of research and development activities, preclinical studies or clinical trials with respect to our current and potential future product candidates;
•
our ability to identify, develop and commercialize our main product candidate, botulinum toxin complex, ABP-450 (prabotulinumtoxinA) injection ("ABP-450");
•
our ability to obtain a Biologics License Application for therapeutic uses of ABP-450;
•
our ability to advance our current and potential future product candidates into, and successfully complete, preclinical studies and clinical trials;
•
our ability to obtain and maintain regulatory approval of our current and potential future product candidates, and any related restrictions, limitations and/or warnings in the label of an approved product candidate;
•
our ability to obtain funding for our operations;
•
our ability to obtain and maintain intellectual property protection for our technologies and any of our product candidates;
•
our ability to successfully commercialize our current and any potential future product candidates;
•
the rate and degree of market acceptance of our current and any potential future product candidates;
•
regulatory developments in the United States and international jurisdictions;
•
potential liability, lawsuits and penalties related to our technologies, product candidates and current and future relationships with third parties;